Indeed, mammalian DRP1 (also clustering into the DRP clade involved in mitochondrial fission in our phylogenetic analysis) is actively being investigated as a target for treatment options for cancer and ischemia-reperfusion injury (27). Here, DNM1L is linked to cancer.